Acute upper gastrointestinal bleeding: a population-based, five-year follow-up study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
CitationHreinsson JP, Jonsson A, Bjornsson ES. Acute upper gastrointestinal bleeding: a population-based, five-year follow-up study. Scand J Gastroenterol. 2021 Jan;56(1):1-5. doi: 10.1080/00365521.2020.1849384.
AbstractObjective: Data on long-term rebleeding risk and mortality in acute upper gastrointestinal bleeding (AUGIB) patients are scarce and comparison to controls are lacking. Aimsof the study were to assess long-term prognosis of AUGIB patients and compare to controls. Methods: A population-based retrospective case-control study conducted at the National University Hospital of Iceland and included all patients who underwent endoscopy in 2010-2011. AUGIB was defined as haematemesis or coffee ground vomiting leading to hospitalization or occurring in a hospitalized patient. Controls underwent endoscopy in 2010-2011, matched for sex/age. Rebleeding was defined as AUGIB >14 days up to five years after index bleeding. Results: Overall, 303 patients had AUGIB, mean age 67 (±18), controls66 years (±19), females, 51 and 46%, respectively. The five-year rebleeding rate for AUGIB patients was 13% (95%CI 9-17%), higher than the rate of bleeding events in controls, 3% (95%CI 1-5%; log-rank <0.001), hazard ratio (HR) 6.0 (95%CI 2.4-15) when correcting for comorbidities, NSAID's, PPI's and antithrombotics. The mortality of AUGIB patients at end of follow-up was higher when compared to controls, 39% (95%CI 49-33%) vs. 26% (95%CI 30-21%), log-rank <0.001, comorbidity-adjusted HR 1.4 (1.1-1.9). A subanalysis of non-variceal AUGIB yielded similar results in regard to rebleeding and mortality rates. Conclusions: AUGIB patients were at 6-fold risk of rebleeding compared to bleeding events in controls at five years of follow-up. Five-year mortality was higher in AUGIB patients when compared to controls even when correcting for age and comorbidities, suggesting that an episode of AUGIB indicates serious frailty. Keywords: GI-bleeding;; mortality;; outcome;; prognosis;; rebleeding; survival;.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- Acute lower gastrointestinal bleeding: A population-based five-year follow-up study.
- Authors: Hreinsson JP, Ægisdottir S, Bjornsson ES
- Issue date: 2019 Dec
- In-hospital acute upper gastrointestinal bleeding: What is the scope of the problem?
- Authors: Haddad FG, El Imad T, Nassani N, Kwok R, Al Moussawi H, Polavarapu A, Ahmed M, El Douaihy Y, Deeb L
- Issue date: 2019 Dec 16
- Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit.
- Authors: Hearnshaw SA, Logan RF, Lowe D, Travis SP, Murphy MF, Palmer KR
- Issue date: 2010 Aug
- Emergency readmission following acute upper gastrointestinal bleeding.
- Authors: Strömdahl M, Helgeson J, Kalaitzakis E
- Issue date: 2017 Jan
- Rockall score in predicting outcomes of elderly patients with acute upper gastrointestinal bleeding.
- Authors: Wang CY, Qin J, Wang J, Sun CY, Cao T, Zhu DD
- Issue date: 2013 Jun 14